• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一种新型大环内酯类抗生素——米卡霉素的体外抗菌活性。一项多中心研究的结果]

[In vitro antibacterial activity of a new macrolide, miokamycin. Results of a multicenter study].

作者信息

Soussy C J, Thabaut A, Bismuth R, Morel C, Berthelot G, Chanal M, Derlot E

机构信息

Service de Bactériologie, Centre Hospitalier Universitaire Henri-Mondor, Creteil.

出版信息

Pathol Biol (Paris). 1989 May;37(5):358-63.

PMID:2674868
Abstract

Minimal inhibitory concentration (MIC) of miokamycin (M) were evaluated by agar dilution for 1,024 bacterial strains isolated in 6 hospitals and classed as a function of susceptibility and resistance to macrolides, lincosamides, streptogramins group (MLS). MIC of M ranged from 0.25 to 4 micrograms/ml (mode MIC 1-2) on Staphylococcus susceptible to MLS and on MLSB inducible strains; M was inactive on MLSB constitutive strains. MIC of M ranged from 0.016 to 4 micrograms/ml (mode MIC 0.12 to 0.5) for Streptococci and Pneumococci susceptible to erythromycin (E) and from 0.12 to greater than 128 for strains resistant to E. Enterococci susceptible to E were inhibited by 0.5 to 2 micrograms/ml (mode MIC 1) and strains resistant to E by 4 to greater than 128. Haemophilus were inhibited by 2 to 64 micrograms/ml (mode MIC 32), Neisseria by 0.12 to 4 (mode MIC 0.5-1) and B. catarrhalis by 0.12 to 8 (mode MIC 1). L. pneumophila was very susceptible to M: MIC 0.016 to 0.12 (mode MIC 0.06). MIC of M ranged generally from 0.5 to 2 micrograms/ml (mode MIC 1) for C. perfringens and from 0.03 to 2 (mode MIC 1) for B. fragilis. Thus, M was shown to be among macrolide antibiotics of resistance non-inducing type on MLSB inducible resistance strains. Its activity was similar to that of spiramycin slightly superior on Staphylococci, slightly inferior on Streptococci and Enterococci, similar on Pneumococci, very superior on Neisseria, Legionella and anaerobes. M had a good activity on Branhamella and, as others macrolides, was poorly active on Haemophilus.

摘要

采用琼脂稀释法对6家医院分离的1024株细菌进行了米卡霉素(M)的最低抑菌浓度(MIC)评估,并根据对大环内酯类、林可酰胺类、链阳菌素类(MLS)的敏感性和耐药性进行分类。对于对MLS敏感的金黄色葡萄球菌和MLSB诱导型菌株,M的MIC范围为0.25至4微克/毫升(MIC模式为1 - 2);M对MLSB组成型菌株无活性。对于对红霉素(E)敏感的链球菌和肺炎球菌,M的MIC范围为0.016至4微克/毫升(MIC模式为0.12至0.5),而对E耐药的菌株MIC范围为0.12至大于128。对E敏感的肠球菌被0.5至2微克/毫升(MIC模式为1)抑制,对E耐药的菌株被4至大于128抑制。嗜血杆菌被2至64微克/毫升(MIC模式为32)抑制,奈瑟菌被0.12至4(MIC模式为0.5 - 1)抑制,卡他莫拉菌被0.12至8(MIC模式为1)抑制。嗜肺军团菌对M非常敏感:MIC为0.016至0.12(MIC模式为0.06)。对于产气荚膜梭菌,M的MIC一般范围为0.5至2微克/毫升(MIC模式为1),对于脆弱拟杆菌,MIC范围为0.03至2(MIC模式为1)。因此,在MLSB诱导耐药菌株中,M被证明是不诱导耐药型的大环内酯类抗生素之一。其活性与螺旋霉素相似,在金黄色葡萄球菌上略强,在链球菌和肠球菌上略弱,在肺炎球菌上相似,在奈瑟菌、军团菌和厌氧菌上非常强。M对布兰汉菌有良好活性,并且与其他大环内酯类一样,对嗜血杆菌活性较差。

相似文献

1
[In vitro antibacterial activity of a new macrolide, miokamycin. Results of a multicenter study].[一种新型大环内酯类抗生素——米卡霉素的体外抗菌活性。一项多中心研究的结果]
Pathol Biol (Paris). 1989 May;37(5):358-63.
2
[In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].一种新型大环内酯类抗生素:米卡霉素的体外抗菌活性。与红霉素和交沙霉素的比较
Pathol Biol (Paris). 1988 May;36(5):370-6.
3
[In vitro antibacterial activity of rokitamycin, a new macrolide antibiotic. Results of a multicenter study].[新型大环内酯类抗生素罗他霉素的体外抗菌活性。一项多中心研究的结果]
Pathol Biol (Paris). 1990 May;38(5):407-12.
4
[In vitro activity of roxithromycin against hospital bacteria and the concordance curve].[罗红霉素对医院细菌的体外活性及协同曲线]
Pathol Biol (Paris). 1988 May;36(5):420-4.
5
[In vitro antibacterial activity of clarithromycin, a new macrolide antibiotic, and regression curve].新型大环内酯类抗生素克拉霉素的体外抗菌活性及回归曲线
Pathol Biol (Paris). 1990 May;38(5):401-6.
6
[In vitro antibacterial activity of lomefloxacin, a new fluoroquinolone, against hospital strains. Results of a multicenter study].[新型氟喹诺酮类药物洛美沙星对医院菌株的体外抗菌活性。一项多中心研究的结果]
Pathol Biol (Paris). 1990 May;38(5):390-6.
7
[Multicenter study of ofloxacin activity on bacteria isolated from a hospital environment].[氧氟沙星对医院环境分离细菌活性的多中心研究] (注:原文中多了一个of,正确表述应该是Multicenter study of ofloxacin activity on bacteria isolated from a hospital environment )
Pathol Biol (Paris). 1986 May;34(5):390-8.
8
[Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].亚胺培南(N-甲酰亚胺基硫霉素)对医院细菌体外作用的多中心研究
Pathol Biol (Paris). 1985 Jun;33(5 Pt 2):487-92.
9
[In vitro antibacterial activity of a new fluoroquinolone, temafloxacin, against hospital isolates. Results of a multicenter study].[新型氟喹诺酮类药物替马沙星对医院分离菌株的体外抗菌活性。一项多中心研究的结果]
Pathol Biol (Paris). 1991 May;39(5):403-9.
10
[In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].[两种新型喹诺酮类药物的体外抗菌活性:A 56619(双氟沙星)和A 56620。与培氟沙星、氧氟沙星和环丙沙星的比较]
Pathol Biol (Paris). 1987 Jun;35(5 Pt 2):759-67.